).
Since the description and popularization of rectal dissection in the "Holy Plane" by Professor R.J. Heald, total mesorectal excision (TME) has become the standard of care for rectal cancer surgery, dramatically impacting local recurrence and functional outcomes.
1-4 TME, however, is a technically challenging procedure, particularly in an obese patient with a narrow pelvis and/or bulky tumor, and can result in significant morbidity including anastomotic complications and genitourinary and bowel dysfunction.
5,6
More than 20 years ago, laparoscopy was introduced as an alternative to the traditional open surgical approach with the hope of facilitating recovery and decreasing morbidity following colon and rectal surgery. The CLASICC trial demonstrated better short-term outcomes, including shorter hospital stay and recovery following laparoscopic surgery when compared with open resections for colorectal cancer, although this study simultaneously raised concerns about positive circumferential resection margin (CRM) following rectal resection. 7 Subsequently, the COLOR II trial revealed noninferiority of a laparoscopic approach to an open approach for rectal cancer. 8 Most recently, two large randomized trials have demonstrated that the laparoscopic approach does not meet criteria for noninferiority compared with an open approach when evaluating a composite of outcomes including CRM positivity and completeness of the TME. 9, 10 The data gathered from these studies will eventually produce long-term oncologic results, but these findings also highlight the opportunity for alternative minimally invasive surgical approaches for rectal cancer. As a result of these studies, coupled with the technical complexity of the surgery, the laparoscopic approach for rectal cancer has not been routinely adopted in the same way it has for colon cancer.
11
Laparoscopic and robotic proctectomies are technically challenging procedures for several reasons, including challenging exposure, tissue retraction, maneuverability, smoke accumulation, and lack of tactile sensation. 12, 13 Furthermore, endoscopic staplers are not designed to be optimally positioned in the narrow pelvis, often requiring multiple stapler applications which can result in angulated, crossing staple lines and an increased risk of anastomotic leak. 14 Ultimately, these technical issues can lead to high conversion to open surgery, lower sphincter preservation rates, and incomplete specimens with positive CRM and distal margins.
In response to these challenges, alternative techniques are being explored as potential improvements to traditional open and laparoscopic techniques. Laparoscopic transanal TME (taTME), also referred to as "bottom-to-up" TME, is emerging as a novel approach that allows for a caudal to cephalad minimally invasive rectal dissection. 18 The primary advantage of this technique is that the surgeon can directly visualize and define the distal resection margin of the tumor and enter the mesorectal dissection plane at its most caudal aspect. Direct visualization allows safe dissection around the critical structures that envelop the narrow pelvis including the vagina, prostate, and pelvic neurovascular structures. Pneumoinflation of the TME plane provides a significant amount of tissue retraction, further facilitating the rectal dissection and mobilization. 12, 13, 19, 20 Consequently, this technique has been found to have improved histologic outcomes with fewer positive circumferential and distal margins compared with other minimally invasive surgical options. 13, [20] [21] [22] While early studies may validate the safety and efficacy of this technique, no long-term oncologic or functional data have been published.
Indications
Indications for taTME include both benign and malignant diseases of the rectum. A consensus was recently published by the Second International Transanal Total Mesorectal Excision Conference 23 held in July 2014. Consensus members suggest that the taTME approach is optimally designed for men, patients with narrow and/or deep pelvis, visceral obesity and/or body mass index (BMI) >30, prostatic hypertrophy, tumor diameter > 4 cm, distorted tissue planes such as irradiated fields, difficult to palpate tumors, and failure to progress from a traditional open or laparoscopic operative approach.
Operative Technique
The patient is placed in a lithotomy position with the right arm tucked and patient secured to the bed. Both the abdominal and perineal fields are prepped. The abdominal portion commences laparoscopically with the objectives of mobilizing the left colon and upper rectum, dividing the superior hemorrhoidal vessels, assisting in the anastomosis, and creating the protective loop ileostomy. The perineal dissection begins with the placement of the GelPOINT Path access sleeve (Applied Medical, Inc., Rancho Santa Margarita, CA) into the anal canal with the proximal/cranial ridge positioned above the levators. The distal/caudal ridge is secured to the perianal skin with sutures (►Fig. 1). A LoneStar Rectractor System (Cooper Surgical, Inc, Stafford, TX) may be used to efface the anus when the semi-rigid access channel cannot be placed atraumatically (►Fig. 2). Alternatively, a narrow anal canal or strictured sphincter complex may require the use of the more malleable Covidien SILS port (Covidien, Minneapolis, MN) for access. Finally, rigid platforms from Storz or Wolf can be used based on surgeon expertise and preference. Very low rectal tumors with invasion of the sphincter complex may require an initial intersphincteric dissection, which can be performed transanally prior to port placement.
Most commonly, pneumorectum is obtained using an AirSeal system (SurgiQuest, Milford, CT), and the tumor is visualized. Cautery marks are placed circumferentially 1 cm distal to the lowest extent of the tumor to mark the exact location for purse-string placement (►Fig. 3). A 2-0 Prolene (Ethicon, Inc., Somerville, NJ) purse string is used to close the rectal lumen either via an open method with a standard needle driver through the access channel or laparoscopically, utilizing luminal insufflation (►Fig. 4). Tight rectal closure prevents stool spillage, isolates the tumor from the dissection plane, and allows insufflation of the TME plane (►Fig. 5).
Full-thickness, circumferential division of the rectum is then performed using electrocautery 1 cm distal to the closed purse string stitch. The TME plane is best entered either posteriorly between the rectum and the presacral plane or anteriorly between the rectum and vagina or prostate (►Fig. 6). In the posterior position, it is critical to bring the Transanal Total Mesorectal Excision Suwanabol, Maykel 121 dissection plane directly downward, staying outside the fascia propria of the mesorectum. A common mistake is to bring the dissection into the intramesorectal plane along the rectal wall. As the TME dissection is followed laterally, the lateral autonomic nerve fibers are encountered, marking the lateral border of the dissection plane. A second common mistake is to follow the plane out laterally and then anteriorly, mobilizing the prostate en bloc with the rectum, potentially resulting in urethral injury. When properly identified and entered, the circumferential TME dissection plane is followed proximally/cranially until the abdominal cavity is entered, either anteriorly or posteriorly. This communication of the two dissection fields is done in a coordinated fashion with the abdominal and pelvic teams providing tissue retraction and exposure for each other. Extraction can be performed through an abdominal incision or transperineally, depending on patient's anatomy and tumor/specimen bulk (►Figs. 7 and 8). The anastomosis is created by placing the EEA anvil in the proximal colon, and a 2-0 Prolene purse string transanally at the top of the open distal rectal stump. A 19F round Blake drain is passed through the rectal stump opening and into the pelvis. The purse string is then tied down snugly around the drain, which acts as a guide for the EEA stapler post. It is important to ensure that the distal rectal stump is completely free of the levators and vagina or prostate prior to placing and tying down the purse string suture. The open EEA stapler post is then inserted into the open end of the drain, and under direct visualization from the abdominal laparoscope, guided through the mid aspect of the rectum. The abdominal surgeon detaches the drain and mates the previously placed 
Reported Experience
The largest study to date was published in the Journal of the American College of Surgeons in 2015. Lacy et al 13 performed a single-arm prospective study evaluating the outcomes from 140 taTME procedures performed between 2011 and 2014. Patients with adenocarcinoma within 15 cm from the anal verge were included. T4 tumors restaged after neoadjuvant therapy and those requiring an abdominoperineal resection were excluded. The authors utilized a simultaneous twosurgeon approach with a meeting point for both teams at the peritoneal reflection. The perianal device used was the GelPOINT Path Transanal Platform with specimen extraction via a Pfannenstiel incision or transanally. Very distal rectal tumors required hand-sewn coloanal anastomosis, whereas most anastomoses were created using a stapled anastomosis (71%). The majority of patients received a protective diverting ileostomy (84%). The authors reported a mean operating time (OR) time of 166 AE 57 minutes (range 60-360 minutes) with no conversions to open and no intraoperative complications. Median length of hospital stay was 6 days (range 3-39 days). Minor complications (Clavien-Dindo I and II) occurred in 24.2% of patients, and 10% experienced major complications (ClavienDindo III and IV). Twelve patients (8.6%) developed anastomotic leak with nine of those patients requiring reoperation. According to Quirke classification, 136 (97.1%) patients had complete specimens. CRM positivity (<1 mm) was reported in nine (6.4%) patients, all of whom were predicted preoperatively by MRI. Lymph node harvest mean was 14.7 AE 6.8. Overall, the authors reported a lower overall conversion rate, comparable complication rates, and superior pathologic outcomes when compared with published series using a laparoscopic approach for rectal cancer. The most common indication for performing taTME is rectal adenocarcinoma located 0 to 15 cm from the anal verge. The most common site of tumor was at the mid to low rectum, and a large proportion of these patients underwent neoadjuvant chemoradiation therapy. Few studies have reported performing taTME for benign disease such as supralevator abscess, malignant polyps, Crohn proctitis, or ulcerative colitis (►Table 1).
26-30

Procedure Variability
The majority of studies published perform taTME in a hybrid fashion with the abdominal portion performed either laparoscopically or robotically. Six studies reported a purely transanal TME with Verheijen et al and Gómez Ruiz et al reporting the use of the robot to perform the transanal portion. [28] [29] [30] [31] [32] [33] The most commonly used transanal platform is the GelPOINT Path over the single-incision laparoscopic surgery (SILS) port or rigid platforms. Hybrid procedures most often report performing the transanal portion before the abdominal portion of the procedure. The majority of studies reported placing a protective stoma if an anastomosis was created. Operative times ranged from as little as 35 minutes for the perianal portion alone to 495 minutes for the entirety of the procedure (►Table 1).
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Fig. 8 Specimen with optimal TME quality. Transanal Total Mesorectal Excision Suwanabol, Maykel 123 Transanal Total Mesorectal Excision Suwanabol, Maykel 34 Rouanet et al were the only authors to report urethral injury in 2 (6.7%) of their cohort of 30 patients. 35 The authors indicated that this occurred early in their experience or in a patient with a large T4 lesion extending into the prostate. Both injuries were repaired intraoperatively, and no long-term effects were noted. A retrospective study that compared 37 patients undergoing taTME and 37 matched patients undergoing laparoscopic TME demonstrated shorter OR time (252 vs. 215 minutes), lower distal margin (1.8 vs. 2.7 cm), and fewer early readmissions (22 vs. 6%) in favor of the taTME approach. 36 No difference was noted in 30-day postoperative complications.
Histological Outcomes
Of those who reported histologic outcomes, lymph node harvest was satisfactory and negative distal and CRMs were superior to previous reports of open and laparoscopic TME. Mean CRM was reported to be 7 to 18 mm with positive CRM in four studies with a rate of 3.1 to 6.4%. 13, [20] [21] [22] Positive distal margins were reported in three series with rates of 2 to 6.3% (►Table 1).
13,20,21
Early Lessons Learned
The taTME technique is safe and feasible, providing potential solutions to the numerous technical challenges plaguing laparoscopic rectal surgery, including tissue retraction, visualization, oncologic margin determination, distal rectal division, and creation of a low pelvic anastomosis. This new surgical approach has been shown to facilitate anastomosis creation in lower tumors and is associated with lower conversion rates. 
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Potential risks to taTME include damage to the urethra at the level of the prostatic urethra, particularly in a previously irradiated pelvis, in patients with prostatic hypertrophy, or following prior prostate surgery. Moreover, it is possible to dissect outside of the TME plane, laterally causing injury to the pelvic sidewall autonomic nerves or posteriorly beneath the endopelvic fascia, exposing the sacral venous plexus.
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Intramesorectal dissection resulting in a compromised mesorectal excision may result in higher rates of local recurrence, although no data have demonstrated this at this time.
42
This technique is specifically suited for patients with mid to low rectal tumors less than 10 to 12 cm from the anal verge. Upper rectal cancers are better approached with a standard open or laparoscopic tumor-specific mesorectal excision. Most authors suggest the greatest opportunity is realized in the most challenging cases with limited pelvic exposure, such as obese males with narrow pelvises. Conversely, the more easily identified anterior dissection plane between the rectum and vagina (compared with the plane separating the low rectum from the prostate) makes this operation more straightforward in women. The choice of operating platform (flexible vs. rigid) is based on surgeon's comfort and patient's anatomy. A two-team approach is strongly recommended to help facilitate the progress of this technically challenging operation.
One of the greatest challenges to the adoption of this technique is related to the steep learning curve and development of a structured team. Regardless of your experience in rectal cancer surgery, this operation turns things "upside down," and requires expert understanding of pelvic anatomy and tissue plane identification, advanced laparoscopic skills, and mastery of low anastomotic techniques. Because of this, early experience should commence with benign conditions such as inflammatory bowel disease.
Successful implementation of a taTME program requires a structured approach. The team of surgeons should enroll in a cadaver-based course to learn from experienced colleagues. A team including OR staff should be assembled at the home institution. A commitment to the program will be solidified with capital purchases of an advanced insufflation system and access platforms. A surgical mentor should be available and present for early cases until mastery has been achieved. There is no reason why multiple surgeons at multiple institutions should have to progress though a challenging learning curve independently; instead, the nuances of the operation should be transferred in real-time with the goal of optimizing patient outcomes.
Scholarly Study
Before this approach can be recommended widely, as with all surgical innovations, the short-and long-term outcomes of the taTME procedure must be recorded and reported. The COLOR III trial is an international, multicenter, randomized superiority trial evaluating transanal TME compared with laparoscopic TME for mid to low rectal cancers. 43 Primary endpoint is involvement of CRM with secondary endpoints of mesorectum completeness, morbidity and mortality, local recurrence, and survival. Accrual of 1,098 patients over a 4-year period is expected. As of October 1, 2015, the OSTRiCh Consortium (Optimizing the Surgical Treatment of Rectal Cancer) taTME Registry opened for recording of all taTME cases being performed in the United States. A multicenter, prospective trial supported by the American Society of Colon and Rectal Surgeons will soon be launched to study outcomes Transanal Total Mesorectal Excision Suwanabol, Maykel 127 of patients at the 10 centers offering this approach in the United States.
Conclusion
Transanal TME is a novel minimally invasive approach that has emerged in response to the challenges associated with traditional open and laparoscopic surgical approaches to rectal cancer. Although taTME is technically challenging, at least initially, its technical advantages as well as the potential oncologic benefit are exciting. Preliminary studies are promising with ongoing studies that will determine long-term oncologic and functional outcomes. The initiation of a taTME program is feasible but must be done systematically using a team approach to ensure safe practices. The potential procedure-specific operative risks including autonomic nerve injury, sphincter injury, and ureteral injury must be recognized and prevented. Moving forward, partnership with industry and the development of new devices that make the operation less technically challenging may facilitate widespread adoption.
